🇺🇸 FDA

Intelligence Platform

Patents

Browse 822 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10369229

Methods and compositions for liposomal formulation of antigens and uses thereof

The Regents of the University of California · Granted Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10357465

Eutectic formulations of cyclobenzaprine hydrochloride

TONIX PHARMA LIMITED · Granted Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10350183

Intravenous baclofen formulations and treatment methods

Regents of the University of Minnesota · Granted Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10350296

Chewable gelatin formulations

Aspire Pharmaceuticals · Granted Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10342876

Process for reducing subvisible particles in a pharmaceutical formulation

REGENERON PHARMACEUTICALS, INC. · Granted Tue Jul 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10335391

Stabilized oxymetazoline formulations and their uses

Aclaris Therapeutics, Inc. · Granted Tue Jul 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10328087

Formulations for solubilizing hormones

Compass Therapeutics LLC · Granted Tue Jun 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10322094

Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride

TONIX PHARMA LIMITED · Granted Tue Jun 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10314790

Sustained-release formulations of topiramate

Supernus Pharmaceuticals, Inc. · Granted Tue Jun 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10307418

Azole pharmaceutical formulations for parenteral administration and methods for preparing

Platform Brightworks Two, Ltd. · Granted Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10300134

Vaccine formulations and methods of preparation and use thereof

Tejas Discovery and Research, LLC · Granted Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10293049

Etanercept formulations stabilized with amino acids

Coherus BioSciences, Inc. · Granted Tue May 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10286072

Methods of manufacturing stable aqueous formulations of adalimumab

Coherus BioSciences, Inc. · Granted Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10286071

Syringe containing stable aqueous formulations of adalimumab

Coherus BioSciences, Inc. · Granted Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10279015

TPP-1 formulations and methods for treating CLN2 disease

BIOMARIN PHARMACEUTICAL INC. · Granted Tue May 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10272039

Topical sodium nitrite formulation

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10272034

Auris formulations for treating otic diseases and conditions

The Regents of the University of California · Granted Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10265319

Formulations of viloxazine

Supernus Pharmaceuticals, Inc. · Granted Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10265397

Formulation for photodynamic therapy

SANOCHEMIA PHARMAZEUTIKA AG · Granted Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10258631

Formulations of testosterone and methods of treatment therewith

The Board of Regents of the University of Texas System · Granted Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10258635

Formulations and compositions of vitamin D analogs for treating and preventing cancer and

Aphios Corporation · Granted Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10220093

Long-acting semi-solid lipid formulations

MIRA PHARMA CORPORATION · Granted Tue Mar 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10221226

LEDGF peptides and formulations thereof for treatment of degenerative disorders

The Regents of the University of Colorado, a Body Corporate · Granted Tue Mar 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10213508

Etanercept formulations stabilized with xylitol

Coherus BioSciences, Inc. · Granted Tue Feb 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted